BlackRock Inc. - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,180
-32.6%
35,225
-3.9%
0.00%
Q2 2023$41,801
-26.9%
36,667
-3.8%
0.00%
Q1 2023$57,165
+4.0%
38,109
+3.4%
0.00%
Q4 2022$54,941
-79.7%
36,873
-78.8%
0.00%
Q3 2022$270,000
-33.5%
173,950
-2.8%
0.00%
Q2 2022$406,000
-84.9%
178,894
-84.7%
0.00%
Q1 2022$2,697,000
-61.3%
1,168,011
-2.9%
0.00%
Q4 2021$6,975,000
-33.7%
1,202,729
+20.2%
0.00%
Q3 2021$10,524,000
+196.6%
1,000,322
+175.2%
0.00%
Q2 2021$3,548,000
-26.6%
363,466
+9.2%
0.00%
Q1 2021$4,834,000332,7000.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
RAYMOND JAMES & ASSOCIATES 13,000$30,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders